Fake Pharma Alert: Viral WhatsApp Image Misuses Medical Dialogues Logo To Falsely Implicate FCM Brands

Written By :  Nidhi Srivastava
Published On 2026-01-21 14:03 GMT   |   Update On 2026-01-21 14:03 GMT
Advertisement

New Delhi: A viral WhatsApp message featuring the Medical Dialogues logo and falsely linking several brands of Ferric Carboxymaltose to a drug alert news report published by Medical Dialogues is fake and maliciously fabricated.

Claim

A viral WhatsApp image circulating on social media claims that Ferric Carboxymaltose injections of specific branded formulations—namely Irozorb FCM (Macleods), Redulid FCM (Torrent), Imax FCM (Aristo), Fur FCM (Corona Remedies), and Vitcofol FCM (FDC)—have been declared Not of Standard Quality (NSQ) by the Central Drugs Standard Control Organisation (CDSCO).

Advertisement

The image falsely carries the Medical Dialogues logo, displays brand names along with product photographs, and presents the content as an official Medical Dialogues drug alert, implying brand-specific regulatory action.

You can access the claim in the following image


Fact Check

This claim is misleading, malicious and falsely attributes a brand specific action to Medical Dialogues and is a fake

What Is The Truth?

Medical Dialogues did report on the official monthly Not of Standard Quality (NSQ) alert issued by the Central Drugs Standard Control Organisation (CDSCO) for November 2025, which listed multiple drug samples declared NSQ after laboratory testing.

The news report can be accessed on the following link:

https://medicaldialogues.in/news/industry/pharma/cdsco/cdsco-alert-64-drug-batches-including-metformin-paracetamol-declared-not-of-standard-quality-in-november-161064

This information was accurately sourced from the official CDSCO website, which publishes monthly drug alert reports detailing batch-wise and sample-specific quality test outcomes conducted by government drug testing laboratories across India.

This can be accessed on the following link:

https://cdsco.gov.in/opencms/opencms/en/Notifications/nsq-drugs/

and on the image below:


In the normal course of reporting, Medical Dialogues only published a factual news report based on the official CDSCO drug alert, which listed certain samples of medicines declared Not of Standard Quality by the regulator. The report strictly reflected information available on the CDSCO website.

Medical Dialogues’ original report faithfully reproduced the regulatory data released by CDSCO, without adding brand promotions, product images, or selective visual emphasis. The report did not attribute NSQ findings to entire set of brands, nor did it imply blanket regulatory action against any manufacturer.

The viral WhatsApp image, on the other hand, has been maliciously altered by third parties by inserting brand names, product photographs, and the Medical Dialogues logo—elements that were never part of the CDSCO alert or Medical Dialogues’ reporting.

Medical Dialogues Team clarifies that it has not created or circulated the viral message currently being shared on WhatsApp. The message falsely uses the Medical Dialogues logo and wrongly attributes a branded CDSCO drug alert to our platform.

Importantly, the original Medical Dialogues article did not name, display, or target any specific brands, nor did it include branding such as Imax FCM or other ferric carboxymaltose products shown in the viral image. The insertion of brand names and product images has been falsely and maliciously done by unknown individuals.

Further , NSQ findings are batch-specific quality observations, not brand-wide bans, and the viral image misrepresents both the CDSCO alert and Medical Dialogues’ journalism.

The viral message is therefore not generated, endorsed, or published by Medical Dialogues, and the use of its logo to lend credibility to this content is a clear case of misattribution and misinformation.

What Is Wrong With The Viral Image?

The viral WhatsApp image:

  • Selectively picks one entry from the CDSCO NSQ list
  • Adds brand names and product images that were never part of the CDSCO alert
  • Creates a misleading impression of brand-specific targeting
  • Falsely attributes the content to Medical Dialogues
  • Risks causing unnecessary panic and reputational damage

This is a classic case of misinformation through visual manipulation.

Meghna A. Singhania, Chief Editor, Medical Dialogues, said “This viral WhatsApp message falsely using the Medical Dialogues logo has been maliciously created and is not authored or endorsed by us in any manner. Our original report did not include brand names or product images. The malicious misuse of our logo and content to spread misinformation is strongly condemned. This message is fake and not generated by Medical Dialogues.

Medical Dialogues Final Take

This viral WhatsApp message falsely using the Medical Dialogues logo has been maliciously created and is not authored or endorsed by us in any way. Someone has deliberately manipulated the content by inserting brand names and product images that were never part of our original article. This WhatsApp message is completely fake and misleading. We strongly condemn the misuse of our identity to spread misinformation.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News